Imatib Imatinib Tablet

Product Overview:Jinishaa Export is a leading name in the international pharmaceutical trade, specializing in the supply of high-grade therapeutic compounds. We are pleased to offer Imatib 400mg (Imatinib) Tablets, manufactured by Cipla, a prescription medication widely recognized for its therapeutic application in treating chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and other malignancies. Our supply chain adheres to strict international export standards, ensuring pharmaceutical-grade quality, secure packaging, and efficient global dispatch. Product Specifications: Active Ingredient: Imatinib Mesylate Brand: Imatib Manufacturer: Cipla Ltd Strength: 400 Mg per tablet CAS Number: 152459-95-5 (Imatinib Mesylate) Molecular Formula: C₂₉H₃₁N₇O (Base) / C₃₀H₃₅N₇O₄S (Mesylate Salt) Molecular Weight: 493.60 g/mol (Base) / 589.71 g/mol (Mesylate Salt) Dosage Form: Oral Tablets (Film-Coated) Packaging: 10 Tablets per Strip / 3 10 Box (Customizable) Storage Conditions: Store below 30 C. Protect from light moisture. HS Code: 3004.90.99 Shelf Life: 36 Months Prescription Requirement: Prescription-only Medicine (Rx only) MOQ: Flexible for Wholesale Distributors and Hospital Networks Global Reach Logistics:Leveraging our established distribution network, Jinishaa Export delivers to key international markets including the United States of America, United Kingdom, Australia, Canada, Germany, France, and the Middle East (UAE, Saudi Arabia) . We provide complete export documentation, including Certificate of Analysis (COA), Certificate of Origin (COO), and regulatory dossiers, to ensure seamless customs clearance. Our team ensures rapid turnaround with discreet, tamper-proof packaging to protect product integrity throughout transit. Why Choose Jinishaa Export? Verifiable Export Excellence: We maintain high standards for pharmaceutical products, ensuring compliance with international pharmacopeial standards (USP/BP/EP) and WHO-GMP guidelines. Competitive Bulk Pricing: We offer aggressive wholesale pricing for pharmaceutical distributors, hospital networks, oncology clinics, and retail pharmacy chains. Regulatory Compliance: We adhere to strict export guidelines and provide complete documentation for prescription medications. Reliable Supply Chain: We prioritize fast shipping with optimized inventory levels and high transaction reliability to serve our international partners. Customer Support: Dedicated export specialists available 24/7 to assist with order tracking, documentation, and after-sales support. Therapeutic Clinical Uses: Chronic Myeloid Leukemia (CML): Imatinib is indicated for the treatment of adults and pediatric patients with Philadelphia chromosome-positive CML in chronic phase, accelerated phase, or blast crisis . Gastrointestinal Stromal Tumors (GIST): It is used for the treatment of adults with KIT (CD117) positive unresectable and/or metastatic malignant GIST . Acute Lymphoblastic Leukemia (ALL): Imatinib is indicated for the treatment of adults with Philadelphia chromosome-positive ALL . Other Indications: It is also used for the treatment of aggressive systemic mastocytosis, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans (DFSP) in certain cases . Mechanism of Action:Imatinib is a tyrosine kinase inhibitor (TKI). It works by blocking the activity of specific kinases, including BCR-ABL, c-KIT, and PDGFR (platelet-derived growth factor receptor). By inhibiting these enzymes, Imatinib prevents the uncontrolled proliferation of cancer cells and induces apoptosis (programmed cell death). It targets the molecular abnormality that drives the growth of cancer cells while sparing healthy cells .

Imatib 100 Tablet is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells).